510(k) device
Atellica IM BRAHMS Procalcitonin (PCT)
Siemens Healthcare Diagnostics, Inc. · Device To Detect And Measure Procalcitonin (Pct) In Human Clinical Specimens (PMT, Class II) · First FDA decision Jul 16, 2018, newest Jul 16, 2018Sepsis
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
0
Naming "Atellica IM BRAHMS"
MAUDE reports
0
Brand "Atellica IM BRAHMS", since 2015
PubMed studies
0
Mentioning "Atellica IM BRAHMS"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Atellica IM BRAHMS Procalcitonin (PCT)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K181002 · Decided Jul 16, 2018 · 91 days after receipt
Device type: Device To Detect And Measure Procalcitonin (Pct) In Human Clinical Specimens (PMT) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Atellica IM BRAHMS", any status and sponsor, newest update first.
No registered device study names "Atellica IM BRAHMS".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Atellica IM BRAHMS", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code PMT
13 reports: 13 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Atellica IM BRAHMS"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code PMT.
- VITROS BRAHMS PCT Reagent Pack and CalibratorsOrtho Clinical Diagnostics · 510(k) 2020
- Vidas B.r.a.h.m.s. Pct (Pct)bioMerieux, Inc. · 510(k) 2016
- Elecys BRAHMS PCT, Elecys BRAHMS PCT CalCheck 5Roche Diagnostics · 510(k) 2016
- B.R.A.H.M.S PCT sensitive KRYPTORBrahms GmbH · De Novo 2016
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.